← Back to Search

Behavioural Intervention

Choice for Colorectal Cancer

N/A
Waitlist Available
Led By Shivan Mehta, MD
Research Sponsored by Abramson Cancer Center of the University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months from initial outreach
Awards & highlights

Study Summary

This trial is testing different ways to get people to participate in colorectal cancer screening by going to their homes.

Eligible Conditions
  • Colorectal Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months from initial outreach
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months from initial outreach for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Colorectal Cancer Screening Completion
Secondary outcome measures
Choice of Colorectal Cancer Screening Test

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: FIT OnlyExperimental Treatment1 Intervention
Participants in this arm will receive a letter from their provider informing them they are overdue for colon cancer screening and requesting their participation in FIT testing. The letter will include a FIT kit with lab requisition and instructions for completion.
Group II: ChoiceExperimental Treatment1 Intervention
Participants in this arm will receive a letter from their provider informing them they are overdue for colon cancer screening and requesting their participation in their choice of either colonoscopy or mailed fecal immunochemical testing (FIT). The letter will include both a referral for the colonoscopy at a local endoscopy enter and a FIT kit with a lab requisition and instructions for completion.
Group III: Colonoscopy OnlyActive Control1 Intervention
Participants in this arm will receive a letter from their provider informing them they are overdue for colon cancer screening and requesting their participation in colonoscopy, and including a referral for the procedure at a local endoscopy center. Participants will be provided a phone number if interested in navigated colonoscopy scheduling.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Choice
2016
N/A
~1980
FIT Only
2021
N/A
~800

Find a Location

Who is running the clinical trial?

Abramson Cancer Center of the University of PennsylvaniaLead Sponsor
359 Previous Clinical Trials
104,295 Total Patients Enrolled
Abramson Cancer Center at Penn MedicineLead Sponsor
387 Previous Clinical Trials
144,895 Total Patients Enrolled
National Comprehensive Cancer NetworkNETWORK
115 Previous Clinical Trials
6,835 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting
Shivan Mehta 2021. "Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04711473.
~234 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top